Approval · Notice of Compliance 31898 · 2023
TPOXX: Notice of Compliance 31898
Issued October 18, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31898
- Date
- October 18, 2023
- Company
- Siga Technologies, Inc.Corvallis, Oregon, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New recommended dose for patients weighing 120 kg or more.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TPOXX | Not yet assigned | — |
Medicinal ingredients
- TECOVIRIMAT MONOHYDRATE 200 MG per CAP